A novel screening approach to the modulation of unfavourable human serum albumin (HSA)/drug interactions

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.1, 1998-07, pp. : 155-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allosteric Modulation of Drug Binding to Human Serum Albumin

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 483-489

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Interactions Between Platinum-/Ruthenium-Based Anticancer Agents and Human Serum Albumin: Development of HSA Carrier for Metal-Based Drugs

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1848-1861

Bentham Science Publishers

Access to resources Recommend Favorite

Human serum albumin (HSA) as a binding agent for detoxification of the blood

By Bhagavan N.V. Peterson C.E.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 159-161

Informa Healthcare

Access to resources Recommend Favorite

Preparation and Characterization of Rivastigmine Loaded Human Serum Albumin (HSA) Nanoparticles

Current Drug Delivery, Vol. 11, Iss. 3, 2014-06 ,pp. : 359-370

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant Human Serum Albumin Fusion Proteins and Novel Applications in Drug Delivery and Therapy

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1899-1907

Bentham Science Publishers

Access to resources Recommend Favorite